drugset
drugset / Trial / NCT03691584

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers

NCT03691584 ↗

Phase 1 Completed 8 enrolled Tetraphase Pharmaceuticals, Inc PRA Health Sciences · collab
NaSingle-groupOpen-labelBasic science

Summary

This is a Phase 1, open-label, randomized, PK and safety study in a maximum of 25 healthy subjects who have provided a bronchoalveolar lavage (BAL) sample.

Timeline

Start
2018-11-26
Primary completion
2019-06-30
Completion
2019-12-18

Drugs

EvaluationDrugModalityDoseRoute
Subject TP 6076 Small molecule 30 mg Intravenous

Indications

No indication recorded.